Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000009.xml
Download PDF
Am J Perinatol 2003; 20(4): 165-172
DOI: 10.1055/s-2003-40604
DOI: 10.1055/s-2003-40604
REVIEW ARTICLE
Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662
In Utero Cocaine Exposure: A Thorny Mix of Science and Mythology
Further Information
Publication History
Publication Date:
21 July 2003 (online)
ABSTRACT
Fetal cocaine exposure has proven to be an area of medicine that has generated more heat than light. Although many reports associate cocaine with a variety of isolated structural anomalies, there is no detectable syndromic clustering, raising doubts about a real causal association or a specific teratogenic action. Potential confounding variables, including the abuse of other drugs, pregnancy deprivations, and socially patterned maternal behaviors, have limited the reliability of observational studies, making it difficult to demonstrate effects solely attributable to cocaine. The clinical expression of in utero cocaine exposure is contextual, critically dependent on the biology/environment interplay. The present work summarizes the fetal structural anomalies that have been associated in the literature with cocaine use during pregnancy, and reviews the putative mechanisms of fetal impairment secondary to cocaine exposure. The final discussion of methodologic issues in cocaine epidemiology highlights the need for innovative approaches to assure that the myths conjured up about “crack babies” are replaced with reliable, high-quality scientific data.
KEYWORDS
Cocaine - fetus - pregnancy - fetal anomalies
REFERENCES
- 1 Koren G, Gladstone D, Robeson C, Robieux J. The perception of teratogenic risk of cocaine. Teratology . 1992; 46 567-571
- 2 Buehler B A, Conover B, Andres R L. Teratogenic potential of cocaine. Semin Perinatol . 1996; 20 93-98
- 3 Koren G. Cocaine and the human fetus: the concept of teratophilia. Neurotoxicol Teratol . 1993; 15 301-304
- 4 Bellini C, Massocco D, Serra G. Prenatal cocaine exposure and the expanding spectrum of brain malformations [letter]. Arch Intern Med . 2000; 160 2393
- 5 Kain Z N, Mayes L C, Ferris C H, Pakes J, Schottenfeld R. Cocaine-abusing parturients undergoing cesarean section: a cohort study. Anesthesiology . 1996; 86 1028-1035
- 6 Gomez-Anson B, Ramsey R G. Pachygyria in a neonate with prenatal cocaine exposure: MR features. J Comput Assist Tomogr . 1994; 18 637-639
- 7 Good W V, Ferriero D M, Golabi M, Kobori J A. Abnormalities of the visual system in infants exposed to cocaine. Ophthalmology . 1992; 99 341-346
- 8 Dominguez R, Aguire Vila-Coro A, Slopis J M, Bohan T P. Brain and ocular abnormalities in infants with in utero exposure to cocaine and other street drugs. Am J Dis Child . 1991; 145 688-695
- 9 Bingol N, Fuchs M, Diaz V, Stone R K, Gromisch D S. Teratogenicity of cocaine in humans. J Pediatr . 1987; 110 93-96
- 10 Finnell R H, Toloyan S, van Waes M, Kauvas P W. Preliminary evidence for cocaine embryopathy in mice. Toxicol Appl Pharmacol . 1990; 103 228-237
- 11 Battin M, Albersheim S, Newman D. Congenital genitourinary tract abnormalities following cocaine exposure in utero. Am J Perinatol . 1995; 12 425-428
- 12 Behnke M, Eyler F D, Conlon M, Wobie K, Stewart N, Cumming W. Incidence and description of structural brain abnormalities in new-borns exposed to cocaine. J Pediatr . 1998; 132 291-294
- 13 Koebbe M J, Golden J A, Bennett G, Finnell R H, Mackler S A. Effects of prenatal cocaine exposure on embryonic expression of sonic hedgehog. Teratology . 1999; 59 12-19
- 14 Volpe J J. Effects of cocaine use on the fetus. New Engl J Med . 1992; 327 399-407
- 15 Stafford J R, Rosen T S, Zaider M, Merriam J C. Prenatal cocaine exposure and the development of the human eye. Ophthalmology . 1994; 101 301-308
- 16 Salamy A, Eldredge L. Risk for ABR abnormalities in the nursery. Electroencephalogr Clin Neurophysiol . 1994; 92 392-395
- 17 Salamy A, Eldredge L, Anderson J, Bull D. Brain-stem transmission time in infants exposed to cocaine in utero. J Pediatr . 1990; 4 627-629
- 18 Little B B, Wilson G N, Jackson G. Is there a cocaine syndrome?. <~>Dysmorphic and anthropometric assessment of infants exposed to cocaine. Teratology . 1996; 54 145-149
- 19 Frank D A, Augustyn M, Zuckerman B S. Neonatal neurobehavioral and neuroanatomic correlates of prenatal cocaine exposure. Ann N Y Acad Sci . 1998; 846 41-50
- 20 Heier L A, Carpanzano C R, Mast J, Brill P W, Winchester P, Deck M D. Maternal cocaine abuse: the spectrum of radiologic abnormalities in the neonatal CNS. Am J Neuroradiol . 1991; 12 951-956
- 21 Chasnoff I, Burns K, Burns W. Cocaine use in pregnancy: perinatal morbidity and mortality. Neurotoxicol Teratol . 1987; 9 291-293
- 22 Durand D J, Espinoza A M, Nickerson B G. Association between prenatal cocaine exposure and sudden infant death syndrome. J Pediatr . 1990; 117 909-911
- 23 Bauchner H, Zuckerman B, McClain M, Frank D, Fried L E, Kayne H. Risk of sudden infant death syndrome among infants with in utero exposure to cocaine. J Pediatr . 1988; 113 831-834
- 24 Martin M L, Khoury M J, Cordero J F, Waters G D. Trends in rates of multiple vascular disruption defects, Atlanta 1968-1989; is there evidence of a cocaine teratogenic epidemic?. Teratology . 1992; 45 647-653
- 25 Lutiger B, Graham K, Einarson T R, Koren G. Relationship between gestational cocaine use and pregnancy outcome: a meta-analysis. Teratology . 1991; 44 405-414
- 26 Addis A, Moretti M E, Syed F A, Einarson T R, Koren G. Fetal effects of cocaine: an updated meta-analysis. Reprod Toxicol . 2001; 15 341-369
- 27 Behnke M, Eyler F D, Garvan C W, Wobie K. The search for congenital malformations in newborns with fetal cocaine exposure. Pediatrics . 2001; 107 E74
- 28 Frank D A, Augustyn M, Knight W G, Pell T, Zuckerman B. Growth, development, and behavior in early childhood following prenatal cocaine exposure. JAMA . 2001; 285 1613-1625
- 29 Woods J R. Maternal and transplacental effects of cocaine. Ann N Y Acad Sci . 1998; 846 1-10
- 30 Woods J R, Plessinger M A, Clark K E. Effect of cocaine on uterine blood flow and fetal oxygenation. JAMA . 1987; 257 957-961
- 31 Sandberg J A, Olsen G D. Cocaine and metabolite concentrations in the fetal guinea pig after chronic maternal cocaine administration. J Pharmacol Exp Ther . 1992; 260 587-591
- 32 Dixon S D. Effects of transplacental exposure to cocaine and methamphetamine on the neonate. West J Med . 1989; 150 436-442
- 33 Hoyme H E, Lyons J K, Dixon S D. Prenatal cocaine exposure and fetal vascular disruption. Pediatrics . 1990; 85 743-747
- 34 Levy M, Koren G. Obstetric and neonatal effects of drugs of abuse. Emerg Med Clin North Am . 1990; 8 633-653
- 35 Sallee F R, Katikaneni L P, McArthur P D, Ibrahim H M, Nesbitt L, Sethuraman G. Head growth in cocaine-exposed infants: relationship to neonate hair level. J Dev Behav Pediatr . 1995; 16 77-81
- 36 Substance Abuse and Mental Health Services Administration Office of Applied Studies. National Household Survey on Drug Abuse: Population Estimates 1999. Rockville, MD:
US Department of Health and Human Services, Public Health Service; 2001;DHHS Project
7190
MissingFormLabel
- 37 Church M W, Overbeck G W. Prenatal cocaine exposure in the Long-Evans rat. Neurotoxicol Teratol . 1990; 12 327-334
- 38 Hume R F, Gingras J L, Martin L S, Hertzberg B S, O'Donnell K J, Killann A P. Ultrasound diagnosis of fetal anomalies associated with in utero cocaine exposure: further support for cocaine-induced vascular disruption teratogenesis. Fetal Diagn Ther . 1994; 9 239-245
- 39 Rieder M J. How much fire under the smoke?. <~>The effects of exposure to cocaine on the fetus. Can Med Assoc J . 1994; 151 1567-1569
- 40 Tronick E Z, Frank D A, Cabral H, Mirochnick M, Zuckerman B. Late dose-response effects of prenatal cocaine exposure on newborn neurobehavioral performance. Pediatrics . 1996; 98 76-83
- 41 Neuspiel D R, Markowitz M, Drucker E. Intrauterine cocaine, lead, and nicotine exposure and fetal growth. Am J Public Health . 1994; 84 1492-1495
- 42 McCance E F, Price L H, Kosten T R, Jatlow P I. Cocaethylene: pharmacology, physiology, and behavioral effects in humans. J Pharmacol Exp Ther . 1995; 274 215-223
- 43 Singer L T, Salvator A, Arendt R, Minnes S, Farkas K, Kliegman R. Effects of cocaine/polydrug excposure and maternal psychological distress on infant birth outcomes. Neurotoxicol Teratol . 2002; 24 127-135
- 44 Lou H C, Hansen D, Nordentroft M. Prenatal stressors of human life affect fetal brain development. Dev Med Child Neurol . 1994; 36 826-832
- 45 Miller Jr M J, Boudreaux M C. A study of antenatal cocaine use: chaos in action. Am J Obstet Gynecol . 1999; 180 1427-1431
- 46 Greenland S, Robins J M, Pearl J. Confounding and collapsibility in casual inference. Stat Sci . 1999; 14 29-46
- 47 Maldonado G, Greenland S. Estimating causal effects. Int J Edpidemiol . 2002; 31 422-429
- 48 Greenland S, Pearl J, Robins J M. Causal diagrams for epidemiologic research. Epidemiol . 1999; 10 37-48